PAA 4.88% 21.5¢ pharmaust limited

Ann: Monepantel reformulation successfully improves dose & taste, page-42

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,690 Posts.
    lightbulb Created with Sketch. 720
    Have any HUMAN PhII trials commenced yet?

    Also, the only real "question" I'd have for management, could the reformulation of the drug, from [I believe] liquid to [I believe] powder....have any [negative] impact?

    Apart from those things....happy to snap up more cheap shares.....
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.